MOLEKULER DOCKING DAN ANALISIS ADMET SENYAWA ANREDERA CORDIFOLIA TERHADAP DPP-4: OBAT DIABETES

Feri Kanti Rahayu

Abstract


Diabetes is a degenerative disease characterized by hyperglycemia. Treatment of type 2 DM usually uses synthetic drugs that have side effects such as sulfonyl urea, biguanine, alpha-glycosidase drugs. Dipeptidyl Peptidase 4 (DPP4) enzyme inhibitor drugs have not been widely studied and have potential for hypoglycemia. This research aims to examine compound isolates from the binahong plant in inhibiting the DPP4 enzyme. The in silico method via molecular docking is the most relevant method in efforts to discover new drugs. Molecular docking is carried out through several stages including modeling and optimization of compound structures, preparation of target proteins and ligands, validation of docking, docking processes, and visualization of interactions and ADMET analysis. The research results show that of the 11 binahong plant compounds there are 3 compounds that have antidiabetic potential, namely 2,3-dihydroxypropyl palmitate, Squale and Linoleic acid, methyl ester with bond energy values respectively -104.1; -101.2; and 90.9 kcal/mol. ADMET analysis of 11 binahong plant compounds shows that the majority of compounds are absorbed through the gastrointestinal tract, distributed and metabolized with the help of the CYP1A2 enzyme and all compounds are not carcinogenic and not mutagenic. Based on the results of this research, it can be concluded that the compounds, namely 2,3-dihydroxypropyl palmitate, Squale and Linoleic acid, methyl ester can inhibit the DPP-4 enzyme and are not toxic so they have the potential to be antidiabetic.

Keywords


diabetes, DPP-4, binahong, moleculer docking

Full Text:

References


K. Suastika et al., “Pedoman Penatalaksanaan Diabetes Mellitus Tipe 2 Pada Individu Dewasa di Bulan Ramadan,” pp. 1–48, 2021, [Online]. Available: https://pbperkeni.or.id/wp-content/uploads/2021/11/22-10-21-Website-Pedoman-Pengelolaan-dan-Pencegahan-DMT2-Ebook.pdf.

L. Hakim, S. Prayogi, M. Kartikasari, F. Kanti Rahayu, and P. Studi Farmasi Fakultas Kesehatan, “Study of Molecular Docking Ligans in Glucagon Like-Peptide-1 Receptor (GLP-1R),” Pharm. Perad. J., vol. 3, no. 1, pp. 64–74, 2023.

T. Fiorentino, A. Prioletta, P. Zuo, and F. Folli, “Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases,” Curr. Pharm. Des., vol. 19, no. 32, pp. 5695–5703, 2013, doi: 10.2174/1381612811319320005.

and Y. T. Yang, Yang, Chong-Yin Shi, Jing Xie, Jia-He Dai, Shui-Lian He 4, “Identification of Potential Dipeptidyl Peptidase,” Molecules, vol. 25, p. 189, 2020.

I. D. F. D. Atlas, International Diabetes Federation, vol. 266, no. 6881. 1955.

S. Padhi, A. K. Nayak, and A. Behera, “Type II diabetes mellitus: a review on recent drug based therapeutics,” Biomed. Pharmacother., vol. 131, p. 110708, 2020, doi: 10.1016/j.biopha.2020.110708.

C. F. Deacon, “Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes,” Front. Endocrinol. (Lausanne)., vol. 10, no. February, 2019, doi: 10.3389/fendo.2019.00080.

F. Husna, “DPP4 Inhibitor sebagai Antidiabetes,” Prosiding, pp. 1–22, 2021.

I. P. Rendi, G. J. Maranata, H. Chaerunisa, N. Nugrahaeni, and S. S. Alfathonah, “Molecular Docking of Compounds in Moringa oleifera Lam with Dipeptidyl Peptidase-4 Receptors as Antidiabetic Candidates,” J. Farm. Dan Ilmu Kefarmasian Indones., vol. 8, no. 3, p. 242, 2021, doi: 10.20473/jfiki.v8i32021.242-249.

J. A. DiMasi, H. G. Grabowski, and R. W. Hansen, “Innovation in the pharmaceutical industry: New estimates of R&D costs,” J. Health Econ., vol. 47, pp. 20–33, 2016, doi: 10.1016/j.jhealeco.2016.01.012.

S. Prayogi, B. A. Dhiani, and A. D. Djalil, “Molecular Docking of Bicycloproline Derivative Synthetic Compounds on Envelope Protein: Anti-SARS-CoV-2 Drug Discovery,” J. Farm. Dan Ilmu Kefarmasian Indones., vol. 10, no. 1, pp. 11–21, 2023, doi: 10.20473/jfiki.v10i12023.11-21.

Z. Ya’u Ibrahim, A. Uzairu, G. Shallangwa, and S. Abechi, “Molecular docking studies, drug-likeness and in-silico ADMET prediction of some novel β-Amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives as elevators of p53 protein levels,” Sci. African, vol. 10, p. e00570, 2020, doi: 10.1016/j.sciaf.2020.e00570.

N. Frimayanti, M. Djohari, and A. N. Khusnah, “Molekular Docking Senyawa Analog Kalkon sebagai Inhibitor untuk Sel Kanker Paru-Paru A549,” J. Ilmu Kefarmasian Indones., vol. 19, no. 1, p. 87, 2021, doi: 10.35814/jifi.v19i1.765.

A. Eriadi, H. Arifin, Z. Rizal, and Barmitoni, “The Effect of Ethanol Extract of Binahong (Anredera cordifolia (Tenore) Steen) Leaves on Science Wound Healing in White Male Rats,” J. Farm. Higea, vol. 7, no. 2, pp. 162–173, 2015.

D. Dwitiyanti, Y. Harahap, B. Elya, and A. Bahtiar, “Binahong (Anredera cordifolia (Tenore) Steen.) Leaf Extract Modulates Fatty Acids and Amino Acids to Lower Blood Glucose in High-Fat Diet-Induced Diabetes Mellitus Rats,” Adv. Pharmacol. Pharm. Sci., vol. 2021, 2021, doi: 10.1155/2021/8869571.

S. D. Saputri and T. C. Darmawan, “Perbandingan Efektifitas Ekstrak Etanol Daun Binahong (Anredera Cordifolio (Ten) Steenis) Dengan MEBO (Moist Exposed Burn Ointment) Terhadap Penyembuhan Luka Bakar Derajat II A Pada Tikus Putih Jantan (Rattus Norvegicus).,” J. Keperawatan, vol. 6, no. 2, 2017, doi: 10.47560/kep.v6i2.133.

A. Sulfianti, N. Firdausi, N. Nurhadi, N. Ngatinem, K. Agustini, and S. Ningsih, “Antidiabetic activity of Anredera cordifolia (Ten.) Stennis extracts with different ethanol percentages: an evaluation based on in vitro, in vivo, and molecular studies,” Pharmacia, vol. 70, no. 1, pp. 39–47, 2023, doi: 10.3897/pharmacia.70.e94899.

F. Feriyani, D. Darmawi, U. Balqis, and R. R. Lubis, “The analysis of binahong leaves potential (Anredera cordifolia) as an alternative treatment of anticataractogenesis,” Open Access Maced. J. Med. Sci., vol. 8, no. B, pp. 820–824, 2020, doi: 10.3889/oamjms.2020.4849.

L. K. R. F. Kartikasari, Mega; Prayogi, syaiful ; Hakim, “SIMULASI MOLECULAR DOCKING KONSTITUEN ASAM LEMAK IKAN GABUS ( Channa striata ) PADA FFAR4 / GPR120 SIMULATION OF MOLECULAR DOCKING FATTY ACID CONSTITUENTS OF,” vol. 3, no. 1, pp. 75–82, 2023.

A. A. Elaine, A. Nisa, N. Tahara, D. Q. Aini, and Z. Syahriar, “In Silico Study of Mangosteen Fruit (Garcinia mangostana L.) as Pancreatic Anticancer Against AKT Kinase,” Indones. J. Biol. Pharm., vol. 3, no. 1, p. 19, 2023, doi: 10.24198/ijbp.v3i1.42601.




DOI: https://doi.org/10.30591/pjif.v14i2.7596

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

===============================================================

Parapemikir : Jurnal Ilmiah Farmasi

Program Studi D-3 Farmasi
Politeknik Harapan Bersama Tegal
Jl. Mataram No.09 Pesurungan Lor Kota Tegal

Telp. +62283 - 352000

Email :[email protected]

 

Copyright: Parapemikir : Jurnal Ilmiah Farmasi p-ISSN:2089-5313 e-ISSN:2549-5062

 

===============================================================

 

Parapemikir Indexed By : 

 

 

Flag Counter

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

View My Stats